Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaehyun Bae

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Scientific Reports|August 10, 2022
The effects of the voglibose on non-alcoholic fatty liver disease in mice modelJaehyun Bae, Ji Young Lee, Eugene Shin, et al.
Wearable Technologies|August 16, 2021
Real-time gait metric estimation for everyday gait training with wearable devices in people poststrokePhilipp Arens, Christopher Siviy, Jaehyun Bae, et al.
American Journal of Physical Medicine & Rehabilitation|August 5, 2017
Reducing Circumduction and Hip Hiking During Hemiparetic Walking Through Targeted Assistance of the Paretic Limb Using a Soft Robotic ExosuitLouis N Awad, Jaehyun Bae, Pawel Kudzia, et al.
Scientific Reports|November 11, 2020
Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expressionMinyoung Lee, Eugene Shin, Jaehyun Bae, et al.
Diabetes & Metabolism Journal|February 22, 2021
Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 PathwayJi-Yeon Lee, Minyoung Lee, Ji Young Lee, et al.
Diabetes, Obesity & Metabolism|January 4, 2021
Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetesMinyoung Lee, Kwang Joon Kim, Tae-Ha Chung, et al.
BMC Medicine|May 7, 2025
Synergistic benefit of thiazolidinedione and sodium-glucose cotransporter 2 inhibitor for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a 24-week, open-label, randomized controlled trialMinyoung Lee, Sukchul Hong, Yongin Cho, et al.
Endocrinology and Metabolism (Seoul, Korea)|January 13, 2016
Effects of Dipeptidyl Peptidase-4 Inhibitors on Hyperglycemia and Blood Cyclosporine Levels in Renal Transplant Patients with Diabetes: A Pilot StudyJaehyun Bae, Min Jung Lee, Eun Yeong Choe, et al.
Head & Neck|June 10, 2014
Follicular variant of papillary thyroid carcinoma with B-type Raf(V600E) showing higher frequency of suspicious sonographic features and multifocalityDong Yeob Shin, Kwang Joon Kim, Sooyun Chang, et al.
Frontiers in Chemistry|October 6, 2022
Multiple resonance type thermally activated delayed fluorescence by dibenzo [1,4] azaborine derivativesJaehyun Bae, Mika Sakai, Youichi Tsuchiya, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Scientific Reports|August 10, 2022
The effects of the voglibose on non-alcoholic fatty liver disease in mice modelJaehyun Bae, Ji Young Lee, Eugene Shin, et al.
Wearable Technologies|August 16, 2021
Real-time gait metric estimation for everyday gait training with wearable devices in people poststrokePhilipp Arens, Christopher Siviy, Jaehyun Bae, et al.
American Journal of Physical Medicine & Rehabilitation|August 5, 2017
Reducing Circumduction and Hip Hiking During Hemiparetic Walking Through Targeted Assistance of the Paretic Limb Using a Soft Robotic ExosuitLouis N Awad, Jaehyun Bae, Pawel Kudzia, et al.
Scientific Reports|November 11, 2020
Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expressionMinyoung Lee, Eugene Shin, Jaehyun Bae, et al.
Diabetes & Metabolism Journal|February 22, 2021
Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 PathwayJi-Yeon Lee, Minyoung Lee, Ji Young Lee, et al.
Diabetes, Obesity & Metabolism|January 4, 2021
Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetesMinyoung Lee, Kwang Joon Kim, Tae-Ha Chung, et al.
BMC Medicine|May 7, 2025
Synergistic benefit of thiazolidinedione and sodium-glucose cotransporter 2 inhibitor for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a 24-week, open-label, randomized controlled trialMinyoung Lee, Sukchul Hong, Yongin Cho, et al.
Endocrinology and Metabolism (Seoul, Korea)|January 13, 2016
Effects of Dipeptidyl Peptidase-4 Inhibitors on Hyperglycemia and Blood Cyclosporine Levels in Renal Transplant Patients with Diabetes: A Pilot StudyJaehyun Bae, Min Jung Lee, Eun Yeong Choe, et al.
Head & Neck|June 10, 2014
Follicular variant of papillary thyroid carcinoma with B-type Raf(V600E) showing higher frequency of suspicious sonographic features and multifocalityDong Yeob Shin, Kwang Joon Kim, Sooyun Chang, et al.
Frontiers in Chemistry|October 6, 2022
Multiple resonance type thermally activated delayed fluorescence by dibenzo [1,4] azaborine derivativesJaehyun Bae, Mika Sakai, Youichi Tsuchiya, et al.
Pageof 5